This list is an analysis based on recent market events. It's not an investment recommendation.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
FAQs
What is Drugs Made In America Acquisition II stock price today?▼
The current price of DMIIR is $0.05 USD — it has decreased by -1.51% in the past 24 hours. Watch Drugs Made In America Acquisition II stock price performance more closely on the chart.
What is Drugs Made In America Acquisition II stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Drugs Made In America Acquisition II stocks are traded under the ticker DMIIR.
What is Drugs Made In America Acquisition II market cap?▼
Today Drugs Made In America Acquisition II has the market capitalization of 3.33M
What is Drugs Made In America Acquisition II revenue for the last year?▼
Drugs Made In America Acquisition II revenue for the last year amounts to 0 USD.
What is Drugs Made In America Acquisition II net income for the last year?▼
DMIIR net income for the last year is 4.13M USD.
How many employees does Drugs Made In America Acquisition II have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Drugs Made In America Acquisition II located?▼
Drugs Made In America Acquisition II operates in the Finance & Payments sector.
When did Drugs Made In America Acquisition II complete a stock split?▼
Drugs Made In America Acquisition II has not had any recent stock splits.
Where is Drugs Made In America Acquisition II headquartered?▼
Drugs Made In America Acquisition II is headquartered in NEW YORK, Cayman Islands.